MA53673A - Procédé de production d'un dérivé de 4-méthoxy pyrrole - Google Patents

Procédé de production d'un dérivé de 4-méthoxy pyrrole

Info

Publication number
MA53673A
MA53673A MA053673A MA53673A MA53673A MA 53673 A MA53673 A MA 53673A MA 053673 A MA053673 A MA 053673A MA 53673 A MA53673 A MA 53673A MA 53673 A MA53673 A MA 53673A
Authority
MA
Morocco
Prior art keywords
production
pyrrole derivative
methoxy pyrrole
methoxy
derivative
Prior art date
Application number
MA053673A
Other languages
English (en)
Inventor
Deok Ki Eom
Jeong Taek Shin
Jeong Hyun Son
Original Assignee
Daewoong Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Pharmaceutical Co Ltd filed Critical Daewoong Pharmaceutical Co Ltd
Publication of MA53673A publication Critical patent/MA53673A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
MA053673A 2018-09-19 2019-09-19 Procédé de production d'un dérivé de 4-méthoxy pyrrole MA53673A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20180112196 2018-09-19
KR1020190110997A KR102126576B1 (ko) 2018-09-19 2019-09-06 4-메톡시 피롤 유도체의 제조 방법

Publications (1)

Publication Number Publication Date
MA53673A true MA53673A (fr) 2022-03-30

Family

ID=69959291

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053673A MA53673A (fr) 2018-09-19 2019-09-19 Procédé de production d'un dérivé de 4-méthoxy pyrrole

Country Status (21)

Country Link
US (1) US12110271B2 (fr)
EP (1) EP3854784A4 (fr)
JP (1) JP7253624B2 (fr)
KR (1) KR102126576B1 (fr)
CN (1) CN112739684B (fr)
AU (1) AU2019343857B2 (fr)
BR (1) BR112021005156A2 (fr)
CL (1) CL2021000639A1 (fr)
CO (1) CO2021003195A2 (fr)
DO (1) DOP2021000042A (fr)
EC (1) ECSP21019076A (fr)
JO (1) JOP20210040A1 (fr)
MA (1) MA53673A (fr)
MX (1) MX2021003137A (fr)
MY (1) MY205351A (fr)
PE (1) PE20211736A1 (fr)
PH (1) PH12021550523A1 (fr)
RU (1) RU2763287C1 (fr)
SA (1) SA521421372B1 (fr)
SG (1) SG11202101919VA (fr)
TN (1) TN2021000035A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102081920B1 (ko) 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
KR102233455B1 (ko) * 2017-06-21 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
KR102126576B1 (ko) 2018-09-19 2020-06-24 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법
CR20230266A (es) 2020-12-18 2023-07-19 Daewoong Pharmaceutical Co Ltd Nueva formulación para administración oral, que comprende 1-(5-(2,4-difluorofenil)-1-((3-fluorofenil)sulfonil)-4-metoxi-1h-pirrol-3-il)-n-metilmetanamina
KR102556500B1 (ko) * 2021-11-19 2023-07-19 하나제약 주식회사 피롤 유도체 또는 이의 약학적 또는 식품학적으로 허용 가능한 염, 및 이를 유효성분으로 포함하는 위장 질환의 예방, 개선 또는 치료용 조성물
TW202411215A (zh) * 2022-05-23 2024-03-16 南韓商日東製藥股份有限公司 6-甲氧基吡啶-3-基衍生物之製造方法
TW202411216A (zh) * 2022-05-23 2024-03-16 南韓商日東製藥股份有限公司 6-甲氧基吡啶-3-基衍生物之製造方法
CN117820193A (zh) * 2022-09-29 2024-04-05 安徽皓元药业有限公司 一种非苏拉赞盐酸盐晶型a及其制备方法
CR20250335A (es) 2023-02-15 2025-09-23 Daewoong Pharmaceutical Co Ltd Procedimiento de fabricación de derivados de 4-metoxipirrol
WO2025023734A1 (fr) * 2023-07-26 2025-01-30 Yunovia Co., Ltd. Procédé de préparation d'intermédiaires de dérivés de 6-méthoxypyridine-3-yle

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592996A (en) 1977-10-10 1981-07-15 Rolland Sa A Acylated pyrrole carboxylic acids and derivatives thereof
SK287857B6 (sk) 2001-05-24 2012-01-04 Eli Lilly And Company Novel pyrrole derivatives as pharmaceutical agents
WO2004026828A1 (fr) 2002-09-20 2004-04-01 Lupin Limited Derives de pyrrole servant de composes anti-mycobacteriens
KR101178747B1 (ko) * 2004-09-30 2012-09-03 다케다 야쿠힌 고교 가부시키가이샤 프로톤 펌프 저해제
HRP20110473T1 (hr) 2005-08-30 2011-07-31 Takeda Pharmaceutical Company Limited Supstituirani derivati 1-heterociklilsulfonil, 2-aminometil, 5-(hetero)-aril 1-h-pirola kao inhibitori kiselinske sekrecije
US7994205B2 (en) 2006-03-31 2011-08-09 Takeda Pharmaceutical Company Limited Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors
MX2008016338A (es) 2006-06-27 2009-01-16 Abbott Lab Derivados de pirrol y sus metodos de uso.
US8933105B2 (en) * 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
JP2011523633A (ja) 2008-05-08 2011-08-18 ブリストル−マイヤーズ スクイブ カンパニー 2−アリールグリシンアミド誘導体
TW201010992A (en) 2008-07-28 2010-03-16 Takeda Pharmaceutical Pharmaceutical composition
BRPI0917705A2 (pt) 2008-08-27 2016-02-16 Takeda Pharmaceutical composto, pró-droga, composição farmacêutica, método para tratar ou prevenir uma doença ou condição, e, uso do composto
WO2010038948A2 (fr) 2008-10-02 2010-04-08 Green Cross Corporation Dérivés de pyrrole 3-carboxamide contenant de l’arylpipérazine pour le traitement de troubles dépressifs
GB0823003D0 (en) 2008-12-17 2009-01-28 Syngenta Participations Ag Pyrrole derivatives with plant growth regulating properties
JP6292736B2 (ja) 2012-11-19 2018-03-14 ジエンス ハンセン ファーマセウティカル カンパニー リミテッド ピロールスルホンアミド誘導体、その製造法およびその医療用途
HUE041725T2 (hu) 2013-04-10 2019-05-28 Daiichi Sankyo Co Ltd (S)-1-(2-hidroxietil)-4-metil-N-[4-(metilszulfonil)fenil]-5-[2-(trifluormetil)fenil]-1H-pirrol-3-karboxamid kristálya
JP2017071553A (ja) 2014-02-25 2017-04-13 味の素株式会社 ヘテロ原子−メチレン−ヘテロ環構造を有する新規化合物
CN104447491B (zh) 2014-11-19 2017-06-23 连云港恒运医药有限公司 含吡咯环质子泵抑制剂的半富马酸盐及其中间体和医药用途
KR101613245B1 (ko) 2015-04-27 2016-04-18 주식회사 대웅제약 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
CN106432191A (zh) * 2015-08-10 2017-02-22 陕西合成药业股份有限公司 一种新的吡咯类衍生物、其制备方法及其在医药上的应用
WO2017164575A1 (fr) 2016-03-25 2017-09-28 Daewoong Pharmaceutical Co.,Ltd. Nouveau sel d'addition d'acide de 1-(5-(2,4-difluorophényl)-1-((3-fluorophényl)sulfonyl)-4-méthoxy-1h-pyrrol-3-yl)-n-méthylméthanamine
KR20170113040A (ko) 2016-03-25 2017-10-12 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민의 신규한 산부가염
KR102081920B1 (ko) 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
CN107879964B (zh) * 2016-09-29 2023-02-10 江苏柯菲平医药股份有限公司 1-(5-(2-氟苯基)-1-(3-(3-甲氧丙氧基)苯磺酰氯)-1h-吡咯-3-基)-n-甲基胺的制备方法
KR102233456B1 (ko) 2017-05-31 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
KR102233455B1 (ko) 2017-06-21 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
CN108503621B (zh) * 2017-12-25 2021-09-14 上海中拓医药科技有限公司 一种富马酸沃诺拉赞的制备方法
KR102126576B1 (ko) 2018-09-19 2020-06-24 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법
WO2020060213A1 (fr) 2018-09-19 2020-03-26 주식회사 대웅제약 Procédé de production d'un dérivé de 4-méthoxy pyrrole
PH12023553209A1 (en) 2021-05-26 2024-02-19 Daewoong Pharmaceutical Co Ltd Medicine container comprising liquid pharmaceutical composition of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n-methylmethanamine

Also Published As

Publication number Publication date
US20210221770A1 (en) 2021-07-22
MX2021003137A (es) 2021-05-14
AU2019343857A1 (en) 2021-04-15
SA521421372B1 (ar) 2024-01-25
BR112021005156A2 (pt) 2021-06-15
RU2763287C1 (ru) 2021-12-28
AU2019343857B2 (en) 2021-12-02
PH12021550523A1 (en) 2022-02-21
US12110271B2 (en) 2024-10-08
DOP2021000042A (es) 2021-05-31
PE20211736A1 (es) 2021-09-06
MY205351A (en) 2024-10-17
CN112739684A (zh) 2021-04-30
CN112739684B (zh) 2024-06-04
KR20200033178A (ko) 2020-03-27
EP3854784A1 (fr) 2021-07-28
CL2021000639A1 (es) 2021-08-06
JP2021535934A (ja) 2021-12-23
NZ773997A (en) 2024-03-22
JP7253624B2 (ja) 2023-04-06
TN2021000035A1 (en) 2022-10-03
SG11202101919VA (en) 2021-04-29
JOP20210040A1 (ar) 2021-03-07
ECSP21019076A (es) 2021-05-31
EP3854784A4 (fr) 2022-03-30
CA3110830A1 (fr) 2020-03-26
KR102126576B1 (ko) 2020-06-24
CO2021003195A2 (es) 2021-04-08

Similar Documents

Publication Publication Date Title
MA53673A (fr) Procédé de production d'un dérivé de 4-méthoxy pyrrole
EP3693373A4 (fr) Procédé pour la production stéréosélective d'un dérivé de pyridone polycyclique substitué
EP3473621A4 (fr) Procédé de production d'un dérivé de diphénylméthane
MA50169A (fr) Procédé de production d'un électrocatalyseur
EP3702121A4 (fr) Procédé de production d'un objet moulé en céramique
EP3318551A4 (fr) Procédé de production d'un composé pyrrole
EP3392236A4 (fr) Procédé de production d'un dérivé amide aromatique
EP3588654A4 (fr) Procédé de production d'une monocellule
EP3653635A4 (fr) Procédé de production d'un intermédiaire herbicide
EP3995475A4 (fr) Procédé de production de 1,3-butadiène
EP3768487C0 (fr) Procédé de micromoulages d'articles
EP4375273A4 (fr) Procédé de production d'un dérivé arylamide
EP3677572A4 (fr) Procédé de production d'un dérivé de pyrazole-4-carboxamide
EP3778560A4 (fr) Procédé de production d'acrylonitrile
EP4079755A4 (fr) Procédé de production d'organoïde
EP3808261A4 (fr) Procédé de production d'une bioélectrode
EP3858886A4 (fr) Procédé de production d'un composé polymère
EP3778687A4 (fr) Procédé de production d'une composition polymérisable
EP3789493A4 (fr) Procédé de production de cello-oligosaccharides
EP3663343A4 (fr) Procédé de production d'un objet poreux
EP4001280A4 (fr) Procédé de production d'un dérivé du phénol
EP3932933A4 (fr) Procédé de production d'amide
EP3831803A4 (fr) Procédé de production de 1,3-bisacyloxy-2-méthylène propane
EP3881848A4 (fr) Procédé de production d'un dérivé d'acide orotique
EP3786139A4 (fr) Procédé de production d'indène